Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults

January 8, 2021 updated by: Amanda R. Bonikowske, Mayo Clinic

The Effect of Interval Training Using Body Weight on Body Composition in Sedentary Overweight and Obese Adults

Body-weight based interval training (IT) performed 3 times per week will lead to reductions in abdominal adiposity and reduce overall body fat percentage in overweight and obese sedentary adults more effectively than moderate intensity continuous training (MICT). Body-weight interval training will improve exercise capacity (peak VO2) in overweight/obese adults.

Study Overview

Detailed Description

Participants will be randomly assigned to one of the two home-based exercise groups.

The MICT group is the standard care group and will be instructed to walk for 30 minutes, 5 days per week at a moderate intensity. The goal is to accumulate 150 minutes of continuous aerobic exercise each week. Participants will be instructed on the use of the Rating of Perceived Exertion (RPE) scale during baseline testing and will be instructed to reach an RPE of 12-16. A heart rate monitor will be worn to monitor exercise intensity. Heart rate should reach ~70% of maximal heart rate.

The IT group will perform 5 body-weight exercises in three progressive phases. During the first 2 weeks the circuit will be completed twice, 30 second intervals, 90 seconds of rest. The exercises will be performed on 3 days of the week with at least one day of rest between exercise days (ideally Monday, Wednesday, Friday). The number of repetitions will increase to a maximum of 4 while the interval and rest periods increase to a maximum of 45 seconds each. The total time spent performing intervals by week 8 will be 15 minutes. A 2 minute warm up and 3 minute cool down will be performed, such as jumping jacks or simply walking. A heart rate monitor will be used to measure exercise intensity. Heart rate should reach approximately 90% of heart rate max during the intervals. Participants will be instructed on the use of the Rating of Perceived Exertion scale during baseline testing and will be instructed to reach an RPE of ≥17 during the high intensity intervals.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults 18-65 years of age
  • Willing and able to provide informed consent
  • Sedentary, overweight and obese adults (<90 minutes of moderate intensity exercise)
  • BMI 25≤35
  • Able to safely begin an exercise program
  • Have a smartphone, and willing and able to download and use the Fitbit app

Exclusion Criteria:

  • Unable to provide informed consent.
  • Known cardiovascular disease, or uncontrolled hypertension,
  • Diagnosed type 1 or 2 diabetes
  • Women who are pregnant or plan to become pregnant in the next 3-4 months
  • Orthopedic injury/limitation or any other contraindications to exercise.
  • Medications that cause weight gain (steroids, HIV-related medications, etc.), or glucose lowering medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Walking
This arm is prescribed standard of care exercise prescription; 30 minutes of moderate intensity walking, 5 days/week.
Walking prescribed to meet current exercise guidelines; 150 minutes per week.
Experimental: Interval Training
This arm is prescribed body-weight based interval training 3 days per week with progressive increase in exercise intervals and sets.
Interval training is prescribed 3 days per week using 5 body weight exercises in a progressive fashion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body fat percent
Time Frame: 12 weeks
DEXA derived body fat %
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Weight
Time Frame: 12 weeks
Weight in kilograms
12 weeks
Change in peak VO2
Time Frame: 12 weeks
Peak VO2 in ml/kg/min
12 weeks
Visceral adipose tissue area
Time Frame: 12 weeks
cm^2
12 weeks
Thigh adipose tissue area
Time Frame: 12 weeks
cm^2
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Amanda R Bonikowske, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2018

Primary Completion (Actual)

January 8, 2021

Study Completion (Actual)

January 8, 2021

Study Registration Dates

First Submitted

April 30, 2018

First Submitted That Met QC Criteria

May 11, 2018

First Posted (Actual)

May 14, 2018

Study Record Updates

Last Update Posted (Actual)

January 11, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 17-010163

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Standard of Care

3
Subscribe